Skip to main content
Clinical Trials/NCT00560625
NCT00560625
Terminated
Not Applicable

Low Dose(1mcg) ACTH Stimulation Test for Assessment of the Hypothalamus-pituitary-adrenal Axis in Patients Treated With Inhaled Busedonide or Fluticasone.

HaEmek Medical Center, Israel1 site in 1 country50 target enrollmentMay 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Adrenal Insufficiency
Sponsor
HaEmek Medical Center, Israel
Enrollment
50
Locations
1
Primary Endpoint
stimulated serum cortisol levels
Status
Terminated
Last Updated
9 years ago

Overview

Brief Summary

Inhaled corticosteroids are largely used in patients with asthma or chronic obstructive lung diseases. The purpose of this study is to determine if the use of inhaled corticosteroids is associated with suppression of endogenous cortisol production, as seen in patients treated with pharmacologic doses of oral or parenteral steroids.

Detailed Description

The normalcy of the hypothalmic-pituitary-adrenal (HPA) axis of enrolled subjects will be assessed by low dose (1mcg) corticotropin (ACTH)stimulation test. Serum cortisol levels will be measured before , 30 minutes and 60 minutes after 1 mcg ACTH intravenous injection.

Registry
clinicaltrials.gov
Start Date
May 2007
End Date
December 2008
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • patients receiving inhaled busedonide or fluticasone at daily dose of 200-800 mcg ' for at least 4 weeks

Exclusion Criteria

  • patients receiving any corticosteroid therapy, except inhaled busedonide or fluticasone.

Outcomes

Primary Outcomes

stimulated serum cortisol levels

Time Frame: within 30 days of treatment

Study Sites (1)

Loading locations...

Similar Trials